Free Trial
NASDAQ:ALEC

Alector (ALEC) Stock Price, News & Analysis

Alector logo
$1.02 -0.07 (-6.42%)
Closing price 04:00 PM Eastern
Extended Trading
$1.08 +0.05 (+5.39%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alector Stock (NASDAQ:ALEC)

Key Stats

Today's Range
$1.01
$1.08
50-Day Range
$1.09
$1.87
52-Week Range
$1.02
$6.78
Volume
820,919 shs
Average Volume
776,668 shs
Market Capitalization
$101.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Hold

Company Overview

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Remove Ads

Alector Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

ALEC MarketRank™: 

Alector scored higher than 73% of companies evaluated by MarketBeat, and ranked 237th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alector has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 3 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Alector has only been the subject of 2 research reports in the past 90 days.

  • Read more about Alector's stock forecast and price target.
  • Earnings Growth

    Earnings for Alector are expected to decrease in the coming year, from ($1.88) to ($1.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alector is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alector is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Alector has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Alector's valuation and earnings.
  • Percentage of Shares Shorted

    7.14% of the float of Alector has been sold short.
  • Short Interest Ratio / Days to Cover

    Alector has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Alector has recently decreased by 3.08%, indicating that investor sentiment is improving.
  • Dividend Yield

    Alector does not currently pay a dividend.

  • Dividend Growth

    Alector does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.14% of the float of Alector has been sold short.
  • Short Interest Ratio / Days to Cover

    Alector has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Alector has recently decreased by 3.08%, indicating that investor sentiment is improving.
  • News Sentiment

    Alector has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Alector this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for ALEC on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Alector to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alector insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.10% of the stock of Alector is held by insiders.

  • Percentage Held by Institutions

    85.83% of the stock of Alector is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alector's insider trading history.
Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

ALEC Stock News Headlines

Alector Provides Executive Leadership Update
This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
Alector to Cut 13% of Workforce
Alector assumed with an Underweight at Morgan Stanley
Alector Full Year 2024 Earnings: Beats Expectations
Q4 2024 Alector Inc Earnings Call
See More Headlines

ALEC Stock Analysis - Frequently Asked Questions

Alector's stock was trading at $1.89 at the beginning of the year. Since then, ALEC shares have decreased by 45.8% and is now trading at $1.0250.
View the best growth stocks for 2025 here
.

Alector, Inc. (NASDAQ:ALEC) issued its quarterly earnings results on Wednesday, February, 26th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.61) by $0.59. The business earned $54.24 million during the quarter, compared to analysts' expectations of $20.41 million. Alector had a negative trailing twelve-month return on equity of 108.77% and a negative net margin of 257.54%.

Alector subsidiaries include Alector LLC.

Alector (ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alector investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Enovix (ENVX), Meta Platforms (META), Rambus (RMBS), Saia (SAIA) and Tesla (TSLA).

Company Calendar

Last Earnings
2/26/2025
Today
4/04/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALEC
Fax
N/A
Employees
270
Year Founded
2013

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$7.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+234.6%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-130,390,000.00
Net Margins
-257.54%
Pretax Margin
-254.70%

Debt

Sales & Book Value

Annual Sales
$100.56 million
Price / Cash Flow
N/A
Book Value
$1.41 per share
Price / Book
0.74

Miscellaneous

Free Float
89,021,000
Market Cap
$103.64 million
Optionable
Optionable
Beta
0.73

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ALEC) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners